NEKTAR THERAPEUTICS (NKTR) › RevenueNEKTAR THERAPEUTICS (NKTR) — RevenueAnnual figures by fiscal year, from SEC filings.2016: $165.44M2017: $307.71M2018: $1.19B2019: $114.62M2020: $152.91M2021: $101.91M2022: $92.06M2023: $90.12M2024: $98.43M2025: $55.23M$55.23M2016Revenue (USD)2025Fiscal YearRevenueChange YoY2025$55.23M-43.9%2024$98.43M+9.2%2023$90.12M-2.1%2022$92.06M-9.7%2021$101.91M-33.4%2020$152.91M+33.4%2019$114.62M-90.4%2018$1.19B+287.8%2017$307.71M+86.0%2016$165.44M—Other metrics: Cost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share